Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06187285
Status:
RECRUITING
Last Update Posted:
2024-01-05
First Post:
2023-12-16
Brief Title:
Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia
Sponsor:
Medanta The Medicity India
Organization:
Medanta The Medicity India
Organization Data
Organization:
Medanta The Medicity India
Class:
OTHER
Study ID:
MMDNB01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Medanta The Medicity India
Lead Sponsor Class:
OTHER
Responsible Party:
Dr Mohammad Shafi Kuchay
Responsible Party Title:
Senior Consultant
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Medanta The Medicity India
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Diabetes Endocrinology Foundation | UNKNOWN |